BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gheibi S, Singh T, da Cunha JPMCM, Fex M, Mulder H. Insulin/Glucose-Responsive Cells Derived from Induced Pluripotent Stem Cells: Disease Modeling and Treatment of Diabetes. Cells 2020;9:E2465. [PMID: 33198288 DOI: 10.3390/cells9112465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ciechanowska A, Gora I, Sabalinska S, Foltynski P, Ladyzynski P. Effect of glucose concentration and culture substrate on HUVECs viability in in vitro cultures: A literature review and own results. Biocybernetics and Biomedical Engineering 2021;41:1390-405. [DOI: 10.1016/j.bbe.2021.04.010] [Reference Citation Analysis]
2 Carvalho AM, Nunes R, Sarmento B. From pluripotent stem cells to bioengineered islets: A challenging journey to diabetes treatment. European Journal of Pharmaceutical Sciences 2022;172:106148. [DOI: 10.1016/j.ejps.2022.106148] [Reference Citation Analysis]
3 Ricci S, Cacialli P. Stem Cell Research Tools in Human Metabolic Disorders: An Overview. Cells 2021;10:2681. [PMID: 34685661 DOI: 10.3390/cells10102681] [Reference Citation Analysis]
4 Lu H, Zhang J, Chen YE, Garcia-Barrio MT. Integration of Transformative Platforms for the Discovery of Causative Genes in Cardiovascular Diseases. Cardiovasc Drugs Ther 2021;35:637-54. [PMID: 33856594 DOI: 10.1007/s10557-021-07175-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]